Phibro Animal Health | PAHC - Passivo Circulante





Passivo Circulante Alterar Data
Align Technology USD 1.91B 2.74M 2026-06
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Aurora Cannabis CAD 66.93M 79M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Henry Schein USD 3.49B 191M 2026-06
Idexx Laboratories USD 1.29B 12.19M 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Merck USD 27.73B 786M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Pacira USD 122.01M 13.22M 2026-06
Phibro Animal Health USD 316.47M 34.6M 2026-06
Prestige Brands USD 153.81M 32.88M 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Zoetis USD 2.06B 8M 2026-06